Developing continuous flow chemistry systems for scalable senolytic drug discovery
flow chemistry
senolytics
drug discovery
automation
aging research
Targeting cellular senescence with senolytic drug cocktails for age-related disease mitigation
senescence
senolytics
aging
combination therapy
age-related diseases
Employing NAD+ boosting to enhance mitochondrial function in aging neurons
NAD+
mitochondrial dysfunction
neuroprotection
aging
sirtuins
Via mitochondrial uncoupling in senescent cell reprogramming therapies
aging interventions
metabolic switching
mitophagy
UCP2
senolysis
For senolytic drug discovery using CRISPR-based senescence biomarkers
senolytic drugs
CRISPR biomarkers
aging research
drug discovery
cellular senescence
Targeting cellular senescence via high-throughput catalyst screening for age-related disease interventions
cellular senescence
high-throughput screening
catalyst discovery
age-related diseases
drug development
Targeting cellular senescence in zero-gravity environments for long-duration space missions
cellular senescence
microgravity aging
space medicine
astronaut health
biogerontology
Targeting mitochondrial dysfunction through novel inflammasome inhibition strategies
mitochondria
inflammasome
aging
metabolic disorders
drug development
Targeting cellular senescence using explainability through disentanglement in AI models
cellular senescence
AI explainability
disentanglement
biomarkers
aging
Enhancing senolytic drug discovery using explainability through disentanglement in neural networks
senolytics
drug discovery
explainable AI
neural networks
feature disentanglement
Via mitochondrial uncoupling for targeted metabolic therapies in aging populations
mitochondrial uncoupling
metabolic therapy
aging
bioenergetics
gerontology
Targeting cellular senescence with enzymatic polymerization for age-related disease intervention
cellular senescence
enzymatic polymerization
age-related diseases
biomaterials
therapeutic intervention